Results 121 to 130 of about 3,661 (213)

Treating genitourinary syndrome of menopause in breast cancer survivors: main challenges and promising strategies [PDF]

Many breast cancer survivors (BCS) suffer the consequences of antineoplastic treatments that induce a hypoestrogenic state, leading to chronic climacteric symptoms such as genitourinary syndrome of menopause (GSM), arousing significant alteration in ...
Anglès Acedo, Sònia, Castelo-Branco Flores, Camil, Cebrecos, Isaac, Mension, Eduard, Torras, Ines   +4 more
core   +1 more source

Vaginal LASER and estrogen comparison in Genitourinary Syndrome of Menopause

Continence
Aim:: This study aims to compare the efficacy of CO2 fractionated laser therapy and topical estrogen treatment in managing Genitourinary Syndrome of Menopause (GSM).
Aytaj Jafarzade, Aydan Biri, Osman Ufuk Ekiz, Tamer Mungan   +3 more
doaj   +1 more source

Dyspareunia in women in preand postmenopausal period [PDF]

Гинекология, 2016
The article presents current views on the multiple pathogenetic mechanisms of development of dyspareunia in women in pre - and postmenopausal women with positions of biopsychosocial approach.
A I Fedorova
doaj  

Safety and efficacy of a new vaginal gel, Feminilove, for the treatment of symptoms associated with vaginal dryness and vulvovaginal atrophy in women: an in vitro and in vivo study [PDF]

, 2021
Antonio González, M.S. Lee, BA Johnson, Laela M. Booshehri, D Grady, Venya Vaddi, C Ip, Caroline M. Mitchell, Michael Krychman, Rima Dardik   +9 more
openalex   +1 more source

Barriers to effective treatment of vaginal atrophy with local estrogen therapy

International Journal of General Medicine, 2013
Suzanne ReiterMid-County Health Center, Largo, FL, USAAbstract: Vaginal atrophy is a common condition among postmenopausal women, among whom many exhibit both vulvovaginal symptoms (eg, dryness, irritation, itching, and pain with intercourse) and urinary
Reiter S
doaj  

Modulation of vulvovaginal atrophy (VVA) by Gelam honey in bilateral oophorectomized rats. [PDF]

Front Endocrinol (Lausanne), 2023
Ismail NH, Ibrahim SF, Mokhtar MH, Yahaya A, Zulkefli AF, Ankasha SJ, Osman K.   +6 more
europepmc   +1 more source

Plurigin Ovules and Plurigin Solution in the Treatment of Vulvovaginal Atrophy in Menopausal Women: A Retrospective Monocentric Observational Study. [PDF]

Medicina (Kaunas), 2023
Langella D.
europepmc   +1 more source

The effectiveness of vitamin D as an alternative to FDA‐approved treatment and other therapies for managing vulvovaginal atrophy and sexual inactivity in postmenopausal women. A systematic review and meta‐analysis [PDF]

Eman Youssef, Mostafa Saad Badie, Doaa Ismail, Aliaa Gamal, Hala Eldamanhoury   +4 more
openalex   +1 more source

Impact of vulvovaginal atrophy therapies on postmenopausal women's quality of life in the CRETA study measured by the Cervantes scale [PDF]

, 2023
Santiago Palacios, Rafael Sánchez‐Borrego, Beatriz Suárez Álvarez, Félix Lugo Salcedo, A. Javier González Calvo, Juan José Quijano Martín, María Jesús Cancelo Hidalgo, María Fasero   +7 more
openalex   +1 more source

Comparison of topical estrogen and platelet-rich plasma injections in the treatment of postmenopausal vaginal atrophy

Frontiers in Medicine
BackgroundPlatelet-rich plasma (PRP) is considered safe and is a low-cost, simple, natural, and minimally invasive method for vaginal rejuvenation. We aimed to compare the effects of hormonal treatment options and PRP use for postmenopausal vulvovaginal ...
Ufuk Atlihan, Can Ata, Onur Yavuz, Huseyin Aytug Avsar, Selcuk Erkilinc, Tevfik Berk Bildaci   +5 more
doaj   +1 more source